{"nct_id":"NCT02607228","title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer","status":"TERMINATED","status_verified_date":"2020-12","start_date":"2015-12-08","start_date_type":"ACTUAL","primary_completion_date":"2017-10-25","primary_completion_date_type":"ACTUAL","completion_date":"2019-09-03","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GILD"]}